Combined deletion of the fibronectin-type III domains and the stalk region results in ligand-independent, constitutive activation of the Interleukin 6 signal-transducing receptor gp130

被引:5
作者
Lamertz, Larissa [1 ]
Floss, Doreen M. [1 ]
Scheller, Juergen [1 ]
机构
[1] Heinrich Heine Univ, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany
关键词
gp130; IL-6; STAT3; Signal transduction; Interleukin; Cytokine signaling; Inflammation; TALL-CYTOKINE-RECEPTOR; STAT3; ACTIVATION; COMPLEX; IL-6; LEADS;
D O I
10.1016/j.cyto.2018.05.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gp130 is the common receptor within the Interleukin 6 cytokine family. Gp130 consists of 6 extracellular domains followed by a small stalk region connecting the last extracellular domain with the trans-membrane domain. Whereas the first three extracellular domains bind to IL-6-type cytokines, the domains 4-6 are needed for correct positioning of the intracellular domains to facilitate Janus kinase activation after cytokine binding. Interestingly, deletion within the cytokine-binding domain resulted in cytokine-independent constitutive activation of mutant gpl 30 receptors. Here, we tested the hypothesis, if deletions of the stalk region and/or domains 4-6 of gp130 might also result in constitutive receptor activation. Shortening of the stalk region of gp130 alone did, however, not result in constitutive receptor activation, whereas a gp130 receptor deletion variant only consisting of the three N-terminal cytokine binding domains but lacking all FNIII domains was biologically inactive. Importantly, combined deletion of the three FNIII domains plus shortening of the stalk region of gp130 resulted in ligand-independent, constitutive receptor activation of gp130.
引用
收藏
页码:428 / 434
页数:7
相关论文
共 24 条
[1]   Stat proteins and oncogenesis [J].
Bromberg, J .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (09) :1139-1142
[2]   Stat3 as an oncogene [J].
Bromberg, JF ;
Wrzeszczynska, MH ;
Devgan, G ;
Zhao, YX ;
Pestell, RG ;
Albanese, C ;
Darnell, JE .
CELL, 1999, 98 (03) :295-303
[3]   Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells [J].
Catlett-Falcone, R ;
Landowski, TH ;
Oshiro, MM ;
Turkson, J ;
Levitzki, A ;
Savino, R ;
Ciliberto, G ;
Moscinski, L ;
Fernández-Luna, JL ;
Nuñez, G ;
Dalton, WS ;
Jove, R .
IMMUNITY, 1999, 10 (01) :105-115
[4]   A bioactive designer cytokine for human hematopoietic progenitor cell expansion [J].
Fischer, M ;
Goldschmitt, J ;
Peschel, C ;
Brakenhoff, JPG ;
Kallen, KJ ;
Wollmer, A ;
Grotzinger, J ;
RoseJohn, S .
NATURE BIOTECHNOLOGY, 1997, 15 (02) :142-145
[5]   Identification of Canonical Tyrosine-dependent and Non-canonical Tyrosine-independent STAT3 Activation Sites in the Intracellular Domain of the Interleukin 23 Receptor [J].
Floss, Doreen M. ;
Mrotzek, Simone ;
Kloecker, Tobias ;
Schroeder, Jutta ;
Groetzinger, Joachim ;
Rose-John, Stefan ;
Scheller, Juergen .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (27) :19386-19400
[6]   Plasticity and cross-talk of Interleukin 6-type cytokines [J].
Garbers, Christoph ;
Hermanns, Heike M. ;
Schaper, Fred ;
Mueller-Newen, Gerhard ;
Groetzinger, Joachim ;
Rose-John, Stefan ;
Scheller, Juergen .
CYTOKINE & GROWTH FACTOR REVIEWS, 2012, 23 (03) :85-97
[7]   PROCESSING OF TUMOR-NECROSIS-FACTOR-ALPHA PRECURSOR BY METALLOPROTEINASES [J].
GEARING, AJH ;
BECKETT, P ;
CHRISTODOULOU, M ;
CHURCHILL, M ;
CLEMENTS, J ;
DAVIDSON, AH ;
DRUMMOND, AH ;
GALLOWAY, WA ;
GILBERT, R ;
GORDON, JL ;
LEBER, TM ;
MANGAN, M ;
MILLER, K ;
NAYEE, P ;
OWEN, K ;
PATEL, S ;
THOMAS, W ;
WELLS, G ;
WOOD, LM ;
WOOLLEY, K .
NATURE, 1994, 370 (6490) :555-557
[8]   PROLIFERATIVE RESPONSES AND BINDING-PROPERTIES OF HEMATOPOIETIC-CELLS TRANSFECTED WITH LOW-AFFINITY RECEPTORS FOR LEUKEMIA INHIBITORY FACTOR, ONCOSTATIN-M, AND CILIARY NEUROTROPHIC FACTOR [J].
GEARING, DP ;
ZIEGLER, SF ;
COMEAU, MR ;
FRIEND, D ;
THOMA, B ;
COSMAN, D ;
PARK, L ;
MOSLEY, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (03) :1119-1123
[9]   Autocrine IL-6 signaling: A key event in tumorigenesis? [J].
Grivennikov, Sergei ;
Karin, Michael .
CANCER CELL, 2008, 13 (01) :7-9
[10]   IL-6 type cytokine receptor complexes:: Hexamer, tetramer or both? [J].
Grötzinger, J ;
Kernebeck, T ;
Kallen, KJ ;
Rose-John, S .
BIOLOGICAL CHEMISTRY, 1999, 380 (7-8) :803-813